Ladies and gentlemen, thank you very much for standing by and welcome to the Second Quarter 2017 Earnings Conference Call. During this presentation, participants are in a listen-only mode and afterwards, we'll conduct a question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded on Wednesday, July 26, 2017. I would now like to turn the conference over to Scott Beamer, Vice President and Chief Financial Officer. Please proceed, sir.

Hello and thank you for joining Stepan Company's second quarter and first half of 2017 financial review. Before we begin, please note that information in this conference call contains forward-looking statements, which are not historical facts. These statements involve risks and uncertainties that could cause actual results to differ materially, including but not limited to prospects of our foreign operations, global and regional economic conditions and other factors outlined in our Securities and Exchange Commission filings. Whether you're joining us online or over the phone, we encourage you to review the Investor Slide Presentation, which we have made available at www.stepan.com, under the Investor Relations section of our website. We make these slides available at approximately the same time as when the earnings release is issued and we hope that you find the information and prospectus helpful. Now with that, I'd like to turn the call over to F. Quinn Stepan Jr., our Chairman, President and Chief Executive Officer.

Thank you, Scott. Good morning and thank you all for joining our call today. The company had a good second quarter delivering record adjusted net income results and record first half of the year, reported and adjusted net income. Specifically, adjusted net income was $30.9 million, up slightly from the same quarter last year. For the first half of the year, adjusted net income was $62.6 million, 4% higher than last year. The quarter benefited from an improving mix and lower manufacturing cost within our Surfactant business. Stronger Surfactant and Specialty Product results were partially offset by a decrease in Polymer operating income. Global rigid Polyol volume declined 13% due to the poor fold of North American volume into the first quarter of 2017, last year one customer in North America and NBI shortages in Europe. Specialty products net sales were up duet to the combination of higher unit margins across the business and higher volumes due to the timing of orders in our flavor business. Despite some challenges, earnings were up slightly versus last year. The quarter benefited from our diversification strategy, increased productivity and improved margins within our Surfactant and Specialty businesses. Rising raw material cost and increased competitive pressure contributed to a disappointing quarter for our Polymer business. The global market for rigid Polyol continues to be strong. As announced in June, we reached an agreement with BASF to acquire its Surfactant production facility in Ecatepec, Mexico and a portion of its associated Surfactant business. The facility is located close to Mexico City and has over 50,000 metric tons of capacity, warehouse space, a large laboratory and an office space to where we will relocate our regional leadership growth. The definitive agreement is subject to closing conditions and the satisfaction of certain other requirement. The transaction is expected to close in the fourth quarter of 2017 and is expected to have minimal impact on our 2017 financial results. We believe this acquisition significantly enhances our market position and supply capabilities for surfactants in Mexico and positions us to grow in both the Consumer and Functional markets for surfactants. Our balance sheet remains strong as our net debt to total capitalization ratio further declined to 10% at quarter end. Our Board of Directors declared a quarterly cash dividend on Stepan's common stock of $0.205 per share, payable on August 31, 2017. At this point, I would like Scott to walk through a few more details about our second quarter results.

Thank you, Quinn. My comments will generally follow the slide presentation, and let's start with slide number four which recaps the quarter. As Quinn stated, adjusted net income for the second quarter was a record $30.9 million or $1.32 per diluted share. In addition, adjusted net income for the first half of 2017 was $62.6 million or $2.68 per diluted share. This was the highest ever first half earnings for the company. Because adjusted net income is a non-GAAP measure, we provide full reconciliations to the comparable GAAP figures, and these can be found in Appendix 2 of the Presentation and Table 2 of the press release. Specifically regarding adjustments to reported net income, this quarter included deferred compensation expense of $2.5 million, or $0.11 per diluted share, compared to deferred compensation expense of $1.4 million, or $0.06 per diluted share in the same period last year. Naturally all employee compensation expenses are reflected in our normal operating net income. However, we allow employees the opportunity to defer their incentive payouts until some future date, and the future payment change is based on the Company's stock price. When the stock price increases, expense is generated as we mark the liability to this market value. Because the future liability of the employee compensation only changes consistently with the change in stock price, we exclude this item from our operational discussion. The second quarter 2017 results also include business restructuring charges related to two of our plants. The current year second quarter includes $300,000 of after-tax decommissioning expenses related to the Canadian plant closure which was announced in 2016 and $200,000 of after-tax severance payments attributable to cost reduction efforts at our Singapore plant. The second quarter of 2016 included $800,000 of after-tax severance expense related to the Canadian plant close. For…

Thank you, Scott. After achieving record first half net income, we remain optimistic about the balance of the year. We believe that our diversification efforts and enhanced internal efficiencies should continue to positively impact the remainder of 2017. During the quarter, we further increased asset utilization across several product lines. The transfer of our production from our Canadian site to our Millsdale site is complete and on track to deliver $2.6 million during the second half of the year. We expect to save $800,000 as a result of the consolidation of Bahia sulfonation volumes into our Vespasiano plant, and $200,000 due to the restructuring actions taken at our Singapore plant in the second half of the year. We will continue to examine our asset base for opportunities to further optimize and improve our production capacity and more efficiently serve our customers around the world. Despite the quarterly decline in our volume, the global Rigid Polyol market remains strong, driven by increased insulation standard and growth in construction. Projects to enhance polyol production for the rigid insulation market at our Millsdale and Wessling sites are underway. Production from our new specialty polyol reactor in Poland, which began production last fall, contributed to the 18% increase in global specialty polyol volumes during the quarter. A new specialty polyol reactor in Columbus, Georgia, should start production later this year. For the full year, we expect Company's capital expenditures to be between $95 million and $105 million, which is certainly lower than our previous expectation. We are committed to deliver profitable volume growth in new geographies, CASE polyols, functional surfactants in Tier 2, Tier 3 consumer product customers. We continue to make inroads in hydraulic fracking, with new surfactant technologies as the oil markets slowly recovers. Our acquisition of Tebras/PBC is ahead of plan. Our intention to acquire a surfactant plant in Mexico later this year supports the Company's growth strategy in Latin America. Our operational efficiency program drive continues to help our Company reduce costs, improve margins and increase the capacity of our production assets. We remain on track to achieve $15 million of pre-tax cash cost out for the full year. Although competitive activity in North America will persist, our Polymer business should benefit from the partial recovery of higher raw material costs and lower manufacturing costs in the second half. Our path to increase shareholder value should continue to advance and we believe earnings for the year should grow. This concludes our prepared remarks. At this time, we would like to turn the call over for questions. Tamra, please review the instructions for the question portion of today's call. Tamra?

Thank you, sir. [Operator Instructions] Our first question comes from the line of Mike Harrison from Seaport Global Securities. Please proceed.

Good morning.

Good morning, Mike.

Hi, Mike.

I wanted to start up by asking about the issues that you charted about in the Polymers business in Europe. In terms of this MDI shortage, did that potentially create some pent-up demand for polyols in Europe or are those just going to be more of sales? I guess the way I am thinking about it is if there is no other material that can be used maybe some of your customers were or working down inventories that they will have to replenish or is there a situation where they could use a substitute material and these sales aren't going to recover?

Yeah, I think, Mike, there were some substitution but and some inventory reduction by our customers. At this point in time, we do anticipate growth in our European business Q3 of 2017 versus 2016 but not a large ring in volumes through the MDI shortfall.

Alright. And then looking at the North America side of the Polymers business you mentioned losing some share with a customer, can you give some color on what's going on there?

Yeah, I think we just - the market is developing, it's an attractive market, there are some tail winds associated with it. We've seen some increased competitor activity in the marketplace. Then most importantly overall the market continues to grow. We do believe that our business in the second half of this year will be equal or greater than our business in the second half of the year benefitting from increased volumes, sequentially improved margins and lower manufacturing costs.

Alright and then looking at the PA business and the decline there, if we normalized for what sounds like it was a one-time sale in the prior year, were volumes up in the PA business? And then I was also hoping if you could comment on the pricing environment for Phthalic Anhydride, I know if you go back a year or two that there were some interesting competitive dynamics going on in the pricing environment there.

Yeah, I would say if you normalize the business, our volumes will be down slightly. And as we look at the pricing environment I would say it remains competitive environment, the margins are up slightly year-over-year in part due to a change in customer mix.

Alright and then just looking over at the Surfactant side of the business, I guess I was wondering if you comment on the stronger Household, Industrial and Institutional business, is that new product within or can you give any other color on what's been driving the strength there?

We see some strength that couple of our large key customers in that segment and then we also have some increased penetration in expanding our product portfolio at some of our smaller Tier 2 and Tier 3 accounts.

So is that something you think would be sustainable into the second half and into 2018?

Yeah, I believe that getting us to this position to grow globally for us and we benefit from the Tebras acquisition is well done in Brazil.

Alright and then last question and I'll get back in queue. But just wondering if you could talk a little bit - give us a little more of a window into pricing versus raw material dynamics in that Polymers segment. Is Q2 really going to be the worst of the year-on-year margin declines and then we should think about it as Q3 maybe still lower year-on-year but not quite as bad and then maybe some improvement as we get into Q4. Can you just give us a sense of what the cadence might look like there?

And again pricing is a dynamic issue and there is mix changes and there are competitive activity in any marketplace. But from where we see it today sequentially Q2 versus Q3, the margins should improve and we would anticipate diethylene glycol potentially decreasing 40% in the fourth quarter and then they also provide some pricing relief in Q4 versus Q3. So generally we anticipate recapturing part of the margins that we've lost in Q2.

All right. Thank you very much.

Thank you, Mike.

Thank you. Our next question comes from the line of David Stratton from Great Lakes Review. Please proceed with your question.

Hi. Thanks for taking the question. To follow-up on the last one, but we've talked about the price increases that you are trying to squeeze in taking effect in April, what are we seeing there as far as the ability and the competitive advantage or competitive landscape that you just mentioned? What are you seeing from competitors? Are they still holding back on raising prices also? Just more color around that would be helpful.

Yeah, generally speaking it's a little bit of a mixed bag. We have seen price movement from a few competitors and others are not moving today. For the most part, given the magnitude of the raw material increase, we're seeing prices trend up in Q3 and we would anticipate again raw material up in Q4.

All right. And then when you look at your tier-2 and tier-3 customers that you're trying to pursue in the Brazil area, how is that shaping up? Are you making the progress you intended? Any information there would be helpful.

Yeah. We're pretty excited about the acquisition and the progress that we're making today. Since the acquisition, we have increased the number of customers who are buying multiple products from that entity and we've increased the number of customers buying multiple products by 50% versus a total acquired customer base. So, we're tracking out of the key metric in the acquisition and we are selling a broader basket of products to those customers and are pleased with the progress.

Excellent. Thank you.

Thank you.

Thank you, sir. [Operator Instructions] Our next question comes from the line of Curt Siegmeyer from Keybanc Capital Markets. Please proceed.

Hey, good morning.

Good morning.

Hi, Curt.

Just a follow-up on the polymer business. You talked about the raw materials recovery that you expect probably more of a 4Q phenomenon than 3Q. It's what you saw in 2Q in terms of the year-over-year decline in op income. Has that kind of put you in too big of a hole to expect to be able to grow earnings in that business this year or do you think once the raw material kind of price cost stabilizes by 4Q, we should be able to maybe pencil in some growth once that bounces up?

What I said earlier is that we anticipate having our second half of the year be greater than 2016 in this business, at this point in time we would not anticipate being able to make up the complete shortfall in the business.

Okay. So, the second half should be up year-over-year though from '16? That's what you said.

On or up, yes. That's our current math.

Got it. Okay. And then just on surfactants, can you just provide a little more color of the $3.8 million in op income growth in that business that you saw in the quarter? How much of that was driven by the lower manufacturing costs?

Give me a second here. Well, I'm looking at Scott. What was the number that we quoted for the [indiscernible]?

Yeah. I would say it's less than $1 million. I think it's a good way to say that.

Yeah, yeah. I think of the total - yeah, less than $1 million and talking about $4 million improvement. Think of manufacturing as being a million, certainly less than half.

And that's good run rate to assume by quarter going forward then?

We may correct that.

It's less than half. But the two together with our Canadian consolidation and the Brazil plant closure, those two together are less than $2 million of the $4 million.

Okay. Got it. Thanks guys.

Thank you.

Thank you, sir. Our next question comes from the line of Chris Meeker from Franklin Templeton. Please proceed with your question.

Hey, good morning, Scott and Quinn.

Good morning.

Good morning.

I had two questions here. Can you just provide some color around what the Mexican surfactant market looks like? What's the attractiveness of the BASS asset that you bought down there? What makes that a more kind of a track to surfactant market than, say, North America?

Well, one, we have a relatively minor position in the Mexican market today. Our plant is located closer to the Mexican border in Matamoros versus the Ecatepec site, which is very near just outside of Mexico City. So, it's much closer to the Mexican customer base. So, we believe that it's an attractive site on which we can call on and there are not only the large multinational customers that are in that region, but also the smaller tier-2 and tier-3 consumer product customers, as well as some functional customers that are down in that area. So, geographically their location is more attractive than ours. And being in Matamoros has been a barrier to us growing our business down in that region for some time. With a large growing middle-class in Mexico, the trend is favorable in terms of just the overall market growth versus that in the United States today. So, a faster growing market and opportunity to better serve the customers from preferred geographic region are things that are attracted to us.

Okay. So, the surfactants will fuel more toward the consumer product, because of that growing middle-class, you don't have the same volume dynamics that you do here in North America?

Yes, that's correct and the business that we're acquiring, I would say, is probably more personal care driven than laundry-driven at this point.

Which were both called within our consumer products.

Yeah. And then we would look to again continue with diversification strategy and introduce some functional product capabilities at the site as well.

Okay. And then you said 50,000 tons - if you could remember what percentage of that is your total surfactant global capacity?

It's the stock of [ph] sand in the ocean.

Okay. Okay. And then just my second question just looking at the surfactants business in total, what do we need to see for that volume to turn positive? Is it growing outside of the North American market, so you get away from the commodity laundry or what are we cheering for? What makes that volume go positive?

Certainly, there is growing demands in the developing and emerging regions of the world. And as the markets evolve from bars to powders to liquids, the market for commodity surfactants will grow up. A big part of our strategy, though, is began to utilize that where we have an existing asset and help base load and provide economy scale, but a key driver for us is the continued diversification of that customer base and not being as dependent on the commodity products as we were in the past.

Okay, thanks guys.

Thank you Mr. Meeker. [Operator Instructions] Our next question comes from the line of Mike Harrison from Seaport Global Securities. Please proceed again, Sir.

Hi, just a couple more from me. It sounds like the Specialty Polymers business was doing quite well. You mentioned the Poland plant that's up and running now and was driving a lot of that volume growth and then mentioned also the Georgia plant that's coming on in the remainder of this year. Can you just give us a better sense of kind of how that market is evolving and how your growth efforts are gaining traction relative to your expectations?

Sure, so I would say, Stepan has a relatively small percentage of the global case marketplace to date and so we are getting full through effects from various customers on a global basis that is helping us to grow the volumes. We've developed some - we have some new technology and are in the process of developing modifications and the next generation of those, which is getting a little bit of traction at this point in the market place also helping us to grow. So, I'd say, relatively small share today. You got technical expertise that is similar to our rigid technical expertise that's allowing us to have constructive conversations with customers in the market place. And we're growing of a relatively small base today as well, so the 18% growth rate is which we quoted. It's good, it's attractive and I would say quite frankly, it's a little bit below plan in Poland today and so we're looking for - we're looking towards our new reactive capabilities in Georgia to help kind of continue momentum in the area though.

Alright, great and then you mentioned within functional Surfactants that both Ag and oil fields were better. Clearly those markets have recovered a little bit from where we were last year, but can you just update us specific to the oil field business. Give us an update on your efforts there following the dissolution of the TIORCO joint venture?

Yeah, so the growth that we're experiencing I would say, none of that has enhanced our recovery. The price of oil is still really too low to have a deal or surfactant technology to be attractive. So, we would have to see sustained prices probably north of $60 per barrel for that market to be interesting to get and could be slightly higher spending on the volatility of oil. So, the growth that we're seeing today is in production chemicals and also in fracking. Again, good growth, profitable growth that we've seen in that space to date, again from a relatively small base, but we're encouraged by the reception we're getting in the market place.

Alright, and then the last one for me is on the Specialty segment. The margins improvements there, obviously we've seen some very choppy performance out of that business. But is this margin that we saw this quarter a high water mark forever or should we kind of look at the weakness last quarter combined with the strength this quarter, it nets out to call it a mid-teens operating margin. Is that sort of the sustainable rate going forward?

Yeah, I would look at the average first half - average between the two quarters as a more indicative opportunity going forward. Our margins will probably be a little bit less than Q2. In the second half, I'm sorry, in the second half of the year. So, I would average the two and then say, it's probably a little bit less based on the timing of orders that we've had in that space. All of our margins for the year will be up.

I got it. Okay, thank you.

Thank you for your question. Mr. Quinn Stepan Jr., there are no further questions at this time. I'll turn the call back to you once again to continue or for your closing remarks.

Thank you very much for joining us on today's call. We appreciate your interest and ownership in Stepan Company. We look forward to reporting to you on our third quarter 2017 call. Thank you very much. Have a great day.

Thank you, Sir. Ladies and gentlemen that does conclude the conference call for today. We thank you all for your participation and ask that you please disconnect your lines. Thank you, once again. Have a great day.